Compare MNMD & MOFG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MNMD | MOFG |
|---|---|---|
| Founded | 2019 | 1934 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Pharmaceuticals and Biotechnology | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 861.6M |
| IPO Year | N/A | N/A |
| Metric | MNMD | MOFG |
|---|---|---|
| Price | $14.93 | $41.22 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 9 | 2 |
| Target Price | $30.33 | ★ $40.50 |
| AVG Volume (30 Days) | ★ 2.3M | 176.4K |
| Earning Date | 03-05-2026 | 01-30-2026 |
| Dividend Yield | N/A | ★ 2.42% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ 2.81 |
| Revenue | N/A | ★ $221,843,000.00 |
| Revenue This Year | N/A | $241.79 |
| Revenue Next Year | N/A | $7.28 |
| P/E Ratio | ★ N/A | $14.25 |
| Revenue Growth | N/A | ★ 504.86 |
| 52 Week Low | $4.70 | $24.62 |
| 52 Week High | $15.29 | $42.38 |
| Indicator | MNMD | MOFG |
|---|---|---|
| Relative Strength Index (RSI) | 64.84 | 60.05 |
| Support Level | $12.88 | $38.56 |
| Resistance Level | $15.20 | $40.55 |
| Average True Range (ATR) | 0.92 | 1.07 |
| MACD | 0.11 | 0.07 |
| Stochastic Oscillator | 85.91 | 91.42 |
Mind Medicine Inc. is a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders. It is developing a pipeline of product candidates targeting neurotransmitter pathways that play key roles in brain health disorders. This includes explicitly pharmaceutically optimized product candidates derived from the psychedelic and empathogen drug classes, including MM120 and MM402, as its key product candidates. The MM120 is a proprietary, pharmaceutically optimized form of lysergide D-tartrate that is being developed to treat generalized anxiety disorder and clinical depressive disorder, and the MM402 is a proprietary form of the R-enantiomer of 3,4-methylenedioxymethamphetamine (MDMA), being developed to treat autism spectrum disorder (ASD).
MidWestOne Financial Group Inc is a bank holding company engaged in delivering relationship-based business and personal banking products and services. The Bank provides commercial loans, real estate loans, agricultural loans, credit card loans, and consumer loans. It also provides deposit products including demand and interest checking accounts, savings accounts, money market accounts, and time deposits. The Bank also provides products and services including treasury management, Zelle, online and mobile banking, debit cards, ATMs, and safe deposit boxes. The Bank offers its products and services through its network of full-service banking offices. the Bank's investments services department offers financial planning, investment advisory, and retail securities brokerage services.